Table 2: Types of treatment and outcome.

Type of therapy Baseline/first visit
( = 15,635)
Last follow-up
(6 months and above)
( = 5,701)
%%

Topical14,74193.65,44195.4
 Topical steroids13,07989.45,02292.3
 Emollient11,52678.84,36080.1
 Tar preparation10,54672.13,78969.6
 Keratolytics8,08955.33,06956.4
 Calcipotriol2,41016.596817.8
 Calcipotriol with betamethasone dipropionate2,20215.181815.0
 Dithranol2421.71001.8
 Others2081.4601.1
Phototherapy4492.91841.2
 NB-UVB39187.116991.8
 BB-UVB286.273.8
 Oral PUVA122.742.2
 Topical PUVA71.621.1
 Bath PUVA40.931.6
 Excimer laser10.200.0
 Others143.152.7
Systemic therapy2,91018.51,4058.9
 Methotrexate2,15478.01,01272.0
 Acitretin51518.727619.6
 Sulphasalazine1766.4674.8
 Cyclosporin1204.3564.0
 Systemic corticosteroids1083.9241.7
 Hydroxyurea180.730.2
Biologics903.3342.4
  Ustekinumab3136.51132.4
  Adalimumab2529.4823.5
  Etanercept1416.5720.6
  Infliximab33.525.9
  Golimumab44.712.9
  Efalizumab11.200.0
  Secukinumab22.400.0
Severity of psoriasis
 BSA < 5%1,82625.266625.7
 BSA 5–10%3,72551.41,28449.6
 BSA > 10–90%1,57221.759823.1
 BSA > 90%1311.8431.7

Mean DLQI8.51 ± 6.588.29 ± 6.56